| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Operating income | 22,190 | 12,370 | 8,251 | 11,162 |
| Interest income (expense), net | 785 | 738 | 506 | 278 |
| Other expense, net | -126 | -101 | -145 | -21 |
| Income from continuing operations before income tax | 22,849 | 13,007 | 8,612 | 11,419 |
| Income tax provision | 6,101 | 3,389 | 1,589 | 3,541 |
| Net income from continuing operations | 16,748 | 9,618 | 7,023 | 7,878 |
| Income from discontinued operations, net of tax | 0 | 0 | - | 217 |
| Net income | 16,748 | 9,618 | 7,023 | 8,095 |
| Basic net income per common share (in dollars per share) | 0.11 | 0.07 | 0.05 | 0.05 |
| Diluted net income per common share (in dollars per share) | 0.11 | 0.06 | 0.05 | 0.05 |
| Weighted average common shares outstanding - basic (in shares) | 148,035,283 | 147,761,332 | 147,272,324 | 146,958,986 |
| Weighted average common shares outstanding - diluted (in shares) | 149,713,653 | 149,317,281 | 149,677,452 | 148,373,631 |
MIMEDX GROUP, INC. (MDXG)
MIMEDX GROUP, INC. (MDXG)